A randomized double-blind placebo-controlled trial of oliceridine, a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy
Oliceridine provided rapid and significant pain relief after bunionectomy in Korean patients, with no serious adverse events reported, supporting its potential as an effective and well-tolerated analgesic option.
Authors
- Jiyong Ahn (ORCID: https://orcid.org/0000-0003-0309-2193)
- B. -K. Cho
- Chan Woo Kang (ORCID: https://orcid.org/0000-0001-5822-5235)
- Bom Soo Kim (ORCID: https://orcid.org/0000-0002-9601-396X)
- Ho Seong Lee (ORCID: https://orcid.org/0000-0002-2336-9498)
- Youngkoo Lee
- Keun-Bae Lee
- Ki-Sun Sung
- Dong Yeon Lee
- Chul Hyun Park
- Youngrak Choi
- Ki-Won Young
- Sunghoo Kim
Institutions
- Ulsan College (KR)
- Inha University (KR)
- Eulji University (KR)
- Soonchunhyang University (KR)
- Asan Medical Center (KR)
- Samsung Medical Center (KR)
- Seoul National University Hospital (KR)
- University of Ulsan (KR)
- Chonnam National University Hospital (KR)
- Chungnam National University Hospital (KR)
- Bumin Hospital Group (KR)
- Chungbuk National University Hospital (KR)
- Yeungnam University (KR)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/03007995.2026.2632422
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00